Source data for Berger et al. Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins
Published: 4 April 2024| Version 1 | DOI: 10.17632/2n9gstvrsy.1
Contributor:
Stephanie BergerDescription
Source data for Berger et al. Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins.
Files
Steps to reproduce
Please see associated manuscript for detailed methods.
Categories
Cell Signaling, Biophysical Chemistry, Protein Engineering, Enzyme-Linked Immunosorbent Assay, Efficacy Study, Protein Binding
Funding
Audacious Project
Howard Hughes Medical Institute
Washington Research Foundation
Center for Washington Entrepreneurial Research Evaluation & Commercialization Hub (WE-REACH)
Mopac Biologics, Inc.
National Institutes of Health
R01 GM092802, R01 AR067288, R35 GM147414, P30 GM124165